CDMO News
UCB Plans Major U.S. Expansion with New Biologics Manufacturing Facility
UCB, a global biopharmaceutical company focused on severe diseases, has announced plans to significantly expand its manufacturing capacity in the United States. The new facility will support the company’s growing pipeline and help ensure dependable access to its medicines. The
16 June 2025
